Signaling Dynamics Flashcards
What is a ratio of signal to effect with no second messengers? What about with second messengers?
1: 1
1:»_space;>1
What do second messengers allow?
modulation, integration, and amplification of signal
Describe how a signal goes from a few molecules to a huge response
Epinephrine is bound to the receptor until K Off is active.
Protein is active as long as GTP is bound to the alpha subunit. PKA phosphorylates multiple proteins and is activates as long as its bound to cAMP. Phosphorylase kinase phosphorylates glycogen phosphorylase, this cleaves off a glucose from the end of glycogen, can take off multiple.
1 unit of epinephrine to 100,000,000 fold of glucose.
What is Emax?
an infinite concentration, no units
What is EC50?
concentration at 1/2 of Emax
Will a more efficacious drug be a higher or lower line?
What will a efficacious drug do to Emax?
higher
increase the Emax
Which drug is more potent? EC50 = 100 Emax = 100 (middle curve) EC50 = 25 Emax = 100 (highest curve) EC50 = 400 Emax =100 (lowest curve)
The drug with the EC50 of 25, it indicates that it takes less of the drug to get to the EC50 so it is more potent
a more efficacious drug will:
be the higher curve or be the lower curve?
The higher curve
What does potency have an effect on and what is the effect?
Decrease the EC50
What is an agonist
ligand binds to a receptor and initiates a response; can be full or partial
What is an antagonist
ligand that binds to a receptor and inhibits the response of the agonist or a compound that inhibits signaling through the receptor; can be competitive or noncompetitive
What does a non-competitive antagonist do?
prevents the car from going regardless if it has a key or not; binds an allosteric site away form the agonist binding site and prevents change in function
What are the four different kinds of agonists?
agonist (full), partial agonist, super agonist, and inverse agonist
What does a full agonist do?
a ligand that binds to the receptor and activates maximal response equal to endogenous ligand
What does a partial agonist do?
a ligand that binds to the receptor and activates less than maximal response; less efficacious than other ligands
What does a super agonist do?
a ligand that binds to the receptor and causes a response greater than an endogenous full agonist
What does an inverse agonist do?
a ligand that binds to the receptor and causes the opposite effect of an agonist; often caused by receptors that have basal signaling activity with no agonist.
What does a competitive antagonist do?
a ligand that binds to the receptor binding site and prevents the agonist from binding
Noncompetitive antagonists?
ligand that binds to the receptor not at the binding site and inhibits a response to the agonist
Antagonists examples
competitive - naloxone (competitive for opioid receptors); non-competitive - ketamine (non-competitive at NMDA receptor); competitive antagonist can be overcome by increasing the concentration of signaling ligand; does not kick out antagonist but competes with antagonist for binding sites; ability to overcome is partially dependent on K-1 of antagonist.
Reversible antagonist
measurable Koff > it comes back off
Irreversible antagonist
no measurable Koff > does not com eback off; covalently bound to receptor
Residence times:
ACH
Morphine
antibodies
ACH - low/sub ms range (Koff - 1000/s)
Morphine - at opioid receptor in low minute range (Koff = -0.01/s)
antibodies - residence times in minutes to months (Koff = 0.001/s)
What does practically irreversible mean?
the off rate of the antagonist is so low physiological functions cannot occur
What will an irreversible antagonist look like?
non-competitive antagonist regardless of where it binds because the agonist cannot compete for binding sites
A dog with a pheochromocytoma (an adrenal tumor secreting catecholamines) is being prepped for surgery; a significant danger during surgery is hemodynamic instability due to massive release of norepinephrine/epinephrine from the tumor; how would we prevent norepinephrine from causing hemodynamic instability?
Want to block the receptor so we want to add a non-competitive antagonist; this will work well bc if we added a competitive antagonist, it could be out-competed.Non-competitive inhibitor should reduce the max epinephrine response no matter what the dose.
Phenoxybenzamine is an irreversible, non-competitive inhibitor of alpha-adrenergic receptors and is often used preoperatively for pheochromocytoma resections.
But low doses of phenoxybenzamine appear to shift the dose-response curve to the right, not depress teh max effect allowing massive doses of epinephrine to overwhelm the blockade
Low (tolerable) doses of phenoxybenzamine appear to shift the dose-response curve to the right, not depress the max effect, allowing massive doses of epinephrine to overwhelm the blockade, why?
Non-competitive inhibitor should reduce the max epinephrine response no matter what the dose.
Phenoxybenzamine is an irreversible, non-competitive inhibitor of alpha-adrenergic receptors and is often used preoperatively for pheochromocytoma resections.
What is pharmacodynamics?
What the drug does to the body
What is pharmacokinetics?
what the body does to the drug.
What does ADME stand for? Which side of pharmaceuticals deals with this?
absorption, distribution, metabolism, elimination; pharmacokinetics
What are the steps for pharmacodynamics?
binding, activation, and systemic response
What is a binding study?
measurements of how much affinity a drug has for a receptor
What is Kd and whats it a ratio of and what are the components of the ratio?
drug concentration at which half of the receptors are occupied. Ratio of k off to k on; k off is how fast the drug leaves the receptor and k on is how fast it binds to the receptor
What does a low kd =
Which way will the curve shift?
high affinity; to the left
what does a high kd = and which way does the curve shift?
low affinity; to the right
What are concentration response studies? What are the dependent on? Are they in vitro or in vivo? What is the drug plotted against?
A measure of how much signal a ligand causes; dependent on binding and signaling which causes teh effect; they are done in vitro.; plotted against the cellular effect.
Formula for concentration
Which type of studies is this better for (in vitro or in vivo)?
mass/volume; in vitro
What is the formula for dose? Which type of studies is this better for (in vitro or in vivo)?
mass/weight or mass/SA; in vivo
What does a dose response study combine and is it done in vitro or in vivo?
combines pharmacodynamic and pharmacokinetic effects; in vivo to determine hw strong a response a given drug elicits
What are dose response plotted against? What are they dependent on and how are they described?
Plotted against the % population with a therapeutic effect; dependent on binding, signaling, and PK effects; described by ED50
What are dose response studies used to describe?
ED50 and potential toxicity of a drug
What is the therapeutic effect of a drug described by and whats it plotted against?
TD50; % pop with toxic effects can be plotted against drug dose
What is plotted for LD50 and what does it mean?
The % population with lethal effects plotted against drug dose; the dose at which 50% of the population die
What two components are needed to determine an effective dose of a drug?
Therapeutic effects and toxic effects
What is the therapeutic index defined as and what does a larger one mean?
LD50/ED50; larger means larger dose difference b/w the therapeutic and toxic doses which indicates that it is generally a safer drug
What is a therapeutic index for a safe drug?
Midrange?
Dangerous?
> > > 100:1 (amoxicillin, pinicillin)
(70:1 or 100:1) morphine and diazepam
15, 4, 2.5, 2, 1.5:1 - cocaine, amphotericin, 5-fluorouracil, digoxin, and cisplatin
Dose response study term
a study to determine the effectiveness of a drug in vivo; described by ED50
ED50 term
drug dose at which 50% of population shows a therapeutic effect
ED99
drug dose at which 99% of population shows a therapeutic effect
TD50
drug dose at which 50% of population shows a toxic effect
LD50
drug dose at which 50% of population shows a lethal effect
LD1
drug dose at which 1% of population shows a lethal effect
Therapeutic index
LD50/ED50 (a comparison of doses)
When ED50 = KD; what is going on with the potency? What about the magnitude? Whats the limiting step? What ratio does this suggest for receptors to signal athways?
Potency is equal to the binding affinity; magnitude is directly related to the % receptors bound. Limited step - receptor binding event; 1:1 ratio
When EC50 > Kdwhat is going on with the potency? What about the magnitude? Whats the limiting step? What does this suggest?
Potency is greater than the binding affinity; magnitude is greater than receptors bound; signaling even is the limiting step; suggest more receptors than signal pathways, meaning there are spare receptors
What do spare receptors create and how?
Redundancy as they have a receptor reserve ready to use if the receptors are deactivated somehow
can signaling pathways with spare receptors signal at full effect?
yes; even in the presence of some irreversible inhibitor